These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22266051)

  • 1. Rational design of new product candidates: the next generation of highly deformable bilayer vesicles for noninvasive, targeted therapy.
    Cevc G
    J Control Release; 2012 Jun; 160(2):135-46. PubMed ID: 22266051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid vesicles and other colloids as drug carriers on the skin.
    Cevc G
    Adv Drug Deliv Rev; 2004 Mar; 56(5):675-711. PubMed ID: 15019752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs.
    Caddeo C; Sales OD; Valenti D; Saurí AR; Fadda AM; Manconi M
    Int J Pharm; 2013 Feb; 443(1-2):128-36. PubMed ID: 23299087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptability and elasticity of the mixed lipid bilayer vesicles containing non-ionic surfactant designed for targeted drug delivery across the skin.
    Wachter C; Vierl U; Cevc G
    J Drug Target; 2008 Aug; 16(7):611-25. PubMed ID: 18686133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80.
    Simões SI; Tapadas JM; Marques CM; Cruz ME; Martins MB; Cevc G
    Eur J Pharm Sci; 2005 Nov; 26(3-4):307-17. PubMed ID: 16129587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale.
    Fernández-García R; Lalatsa A; Statts L; Bolás-Fernández F; Ballesteros MP; Serrano DR
    Int J Pharm; 2020 Jan; 573():118817. PubMed ID: 31678520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations.
    Cevc G; Mazgareanu S; Rother M; Vierl U
    Int J Pharm; 2008 Jul; 359(1-2):190-7. PubMed ID: 18499370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of original bioactive formulations based on sugar-surfactant/non-steroidal anti-inflammatory catanionic self-assemblies: a new way of dermal drug delivery.
    Consola S; Blanzat M; Perez E; Garrigues JC; Bordat P; Rico-Lattes I
    Chemistry; 2007; 13(11):3039-47. PubMed ID: 17285653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects of locally applied enzyme-loaded ultradeformable vesicles on an acute cutaneous model.
    Simões S; Marques C; Cruz ME; Martins MB
    J Microencapsul; 2009 Nov; 26(7):649-58. PubMed ID: 19839801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of membrane softeners on rigidity of lipid vesicle bilayers: Derivation from vesicle size changes.
    Elsayed MMA; Ibrahim MM; Cevc G
    Chem Phys Lipids; 2018 Jan; 210():98-108. PubMed ID: 29107604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
    Sharma G; Goyal H; Thakur K; Raza K; Katare OP
    Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterisation of novel analgesic product based on self-regulating drug carriers.
    Cevc G; Vierl U; Mazgareanu S
    Int J Pharm; 2008 Aug; 360(1-2):18-28. PubMed ID: 18524509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PG-liposomes: novel lipid vesicles for skin delivery of drugs.
    Elsayed MM; Abdallah OY; Naggar VF; Khalafallah NM
    J Pharm Pharmacol; 2007 Oct; 59(10):1447-50. PubMed ID: 17910822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology and the transdermal route: A state of the art review and critical appraisal.
    Cevc G; Vierl U
    J Control Release; 2010 Feb; 141(3):277-99. PubMed ID: 19850095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-drug delivery system with sequential release using titania nanotube arrays.
    Aw MS; Addai-Mensah J; Losic D
    Chem Commun (Camb); 2012 Apr; 48(27):3348-50. PubMed ID: 22367413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin penetration behaviour of liposomes as a function of their composition.
    Gillet A; Lecomte F; Hubert P; Ducat E; Evrard B; Piel G
    Eur J Pharm Biopharm; 2011 Sep; 79(1):43-53. PubMed ID: 21272638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidics fabrication of monodisperse biocompatible phospholipid vesicles for encapsulation and delivery of hydrophilic drug or active compound.
    Kong F; Zhang X; Hai M
    Langmuir; 2014 Apr; 30(13):3905-12. PubMed ID: 24552433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine.
    Shaikh KS; Chellampillai B; Pawar AP
    Drug Dev Ind Pharm; 2010 Aug; 36(8):946-53. PubMed ID: 20196642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels.
    Cevc G; Mazgareanu S; Rother M
    Int J Pharm; 2008 Aug; 360(1-2):29-39. PubMed ID: 18337027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.